Study identification

EU PAS number

EUPAS106670

Study ID

106671

Official title and acronym

mRNA-1273-P901, Real-World Study of the Effectiveness of Moderna COVID-19 Vaccine

DARWIN EU® study

No

Study countries

United States

Study description

This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC).

Study status

Ongoing
Research institutions and networks

Institutions

Contact details

Clinical Trial Disclosure ModernaTX

Primary lead investigator

Study timelines

Date when funding contract was signed

Actual:

Study start date

Actual:

Data analysis start date

Planned:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

ModernaTX
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)